EFFIX
Live / Allowed — Approved for publication (as of 10 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79443342
- Mark type
- Stylized text
- Filed
- 26 Jun 2025
- Attorney of record
- Eric Lamb
Goods and services
- Class 001 — Chemicals: Biological preparations, other than for medical or veterinary purposes, for use in industry and science in connection with genetically modified cells and vectors for production of human, animal and synthetic proteins, for clinical and commercial purposes in scientific research and for use in pharmaceutical research; preparations of microorganisms, other than for medical and veterinary use; bacterial preparations, other than for medical and veterinary use; bacteriological preparations, other than for medical and veterinary use for use in industry and science in connection with genetically modified cells and vectors for production of human, animal and synthetic proteins, for clinical and commercial purposes in scientific research and for use in pharmaceutical research; biochemical reagents for scientific use; biochemical reagents, other than for medical use; collagen for industrial purposes; proteins for use in manufacture; protein for use in manufacture, namely, recombinant proteins expressed via microbial systems; proteins for industrial purposes; chemical additives for use in the manufacture of cosmetics; proteins for the food industry; proteins for use in the manufacture of cosmetics.
- Class 005 — Pharmaceuticals: Biological preparations for medical purposes for the prevention and treatment of cancer, autoimmune diseases, infectious diseases, metabolic diseases, hereditary disorders, skin aging and aesthetic dermatological conditions; preparations of microorganisms for medical use; pharmaceutical preparations for use in the prevention and treatment of cancer, autoimmune diseases, infectious diseases, metabolic diseases, hereditary disorders, skin aging and aesthetic dermatological conditions; medicines for human purposes for use in the prevention and treatment of cancer, autoimmune diseases, infectious diseases, metabolic diseases, hereditary disorders, skin aging and aesthetic dermatological conditions; cells for medical use; bacterial preparations for medical use; all the above-mentioned goods not intended to be used in the veterinary field.
- Class 040 — Treatment of materials: Custom manufacture of nanobodies, enzymes, cytokine, antibody fragments, virus-like particles, pDNA, antigens peptides, recombinant proteins, and vectors for others; processing and treatment of chemical reagents, namely, custom synthesis and manufacture of reagents for scientific or medical research use in the field of drug conjugation; custom manufacturing of cosmetics; custom manufacturing of pharmaceuticals; custom manufacture of biological preparations; custom manufacturing of biomedical preparations; custom manufacturing of biotechnology drugs; custom manufacturing of antibody drugs; custom manufacturing of biopharmaceuticals
- Class 042 — Scientific and technological services: Consulting services in the field of technology development in the field of protein-related biological research; research and development of new products for others; scientific research and development; biochemical research and analysis; pharmaceutical products development services; pharmaceutical research services; research in the field of synthetic biology; development of pharmaceutical preparations and medicines; biomedical research services; scientific research and development services in the field of gene expression systems.
Owner
Prosecution history
- 10 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Sept 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Sept 2026 — EXAMINER'S AMENDMENT ENTERED
- 10 Sept 2026 — EXAMINERS AMENDMENT E-MAILED
- 10 Sept 2026 — EXAMINERS AMENDMENT -WRITTEN
- 08 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Sept 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Sept 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Sept 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 Sept 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 09 Apr 2026 — REFUSAL PROCESSED BY IB
- 20 Mar 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 20 Mar 2026 — REFUSAL PROCESSED BY MPU